Clinical Trial Update: Bevacizumab in Advanced Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial of bevacizumab for advanced hepatocellular carcinoma; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN